PHASE Scientific International Limited, a Hong Kong-based biotechnology company, announced Tuesday the successful completion of a $34 million Series A funding round. The firm said in a statement that this represents the largest Series A raise in Asia’s diagnostic technology sector since 2019, reflecting robust investor conviction in PHASE Scientific’s innovative PHASIFY™ technology and ambitious growth strategy. The funding round is led by a private equity fund managed by...

Betamek Berhad, a Malaysia-based original design manufacturer (ODM), has partnered with SiGenex Global Holdings Pte. Ltd. (SiGenex), a Singapore-based technology firm, for artificial intelligence (AI) genomics diagnostic and sequencing solution. Betamek said in a statement that the firm, through its wholly-owned subsidiary Betamek Research Sdn. Bhd. (BRSB) has entered into a memorandum of collaboration (MoC) with SiGenex for the partnership. The collaboration aims to jointly explore a...

Southeast Asia’s biotech and healthtech sectors are gaining momentum, driven by government-led initiatives like Singapore’s National Precision Medicine Strategy and Thailand’s “Thailand 4.0” plan. These efforts aim to drive R&D and deliver more personalized, data-driven healthcare solutions. Artificial intelligence sits at the heart of this transformation, promising faster drug discovery, improved diagnostics, and more targeted treatments. Yet despite its...

Telehealth services are seeing a major shift in the Asia-Pacific (APAC) region, with artificial intelligence playing a central role. From automated patient monitoring to real-time diagnostics, AI addresses critical healthcare challenges across clinical practices. But how instrumental is AI in helping improve patient outcomes in the region, and where do APAC countries stand in its implementation? The state of telehealth in APAC With the APAC telehealth industry reaching $8.07 billion in 2024...

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing. The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund, alongside Highlight Capital and SEEDS Capital, Nuevocor said in a statement on Tuesday. Nuevocor also...

Creador, a Malaysia-based private equity firm in South and Southeast Asia, has announced the acquisition of up to 13 percent in FPT Long Chau Investment JSC (Long Chau), one of Vietnam’s leading pharmacy chains. This marks the first ever fundraise by Long Chau and the second investment made in Vietnam by Creador, Creador said in a statement on last Friday. Long Chau has grown from four stores in 2017 to over 2,000 pharmacies and over 140 vaccination centers in Vietnam today. It is...

By the time you finish reading this article, somewhere in the world, a robot will have helped a stroke survivor move an arm, reminded an elderly patient to take their medication, or encouraged a toddler to get active. Physical artificial intelligence (AI) isn’t just testing our technological capability. It is testing our values. Across aged care, education, and hospitals, physical AI – robots that move, sense, and interact in the real world – is emerging as a powerful and...

HealthMetrics, a Malaysia-based digital third-party administrator (TPA), announced the official launch of HealthMetrics Indonesia – uniting the longstanding expertise of Across Asia Assist Indonesia (AAA) with its advanced digital infrastructure to create a single, integrated digital TPA powerhouse poised to transform healthcare administration in Indonesia and Southeast Asia. HealthMetrics said in a statement on last Friday that for over a decade, Across Asia Assist Indonesia has...

Healthcare accreditation is a vital benchmark for quality, safety, and compliance in medical institutions. In Southeast Asia and the broader Asia-Pacific (APAC) region, artificial intelligence (AI) is emerging as a transformative force, streamlining accreditation processes and enhancing healthcare delivery. AI’s role in streamlining accreditation AI technologies are revolutionizing how healthcare institutions approach accreditation by automating complex tasks and enhancing data...

The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore. The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia. The funding from LKSF and TT will also...

Ceva Animal Health (Ceva), the world’s fifth-largest animal health company, said the Singapore-based global investment firm Temasek has renewed its investment in the company. Ceva announced in a statement on Monday the restructuring of its capital. According to the statement, all investors including pure investors led by Temasek, have renewed their investment, demonstrating their confidence in the company’s ability to continue its sustained growth. It noted the long-standing...

Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement on last Sunday. According to the statement, the reinvestment by TPG Asia and investment from GIC and...